Literature DB >> 19909731

NCAM-mimetic, FGL peptide, restores disrupted fibroblast growth factor receptor (FGFR) phosphorylation and FGFR mediated signaling in neural cell adhesion molecule (NCAM)-deficient mice.

Anu Aonurm-Helm1, Vladimir Berezin, Elisabeth Bock, Alexander Zharkovsky.   

Abstract

Neural cell adhesion molecule (NCAM) is a membrane-bound glycoprotein expressed on the surface of neuronal and glial cells. Previous in vitro studies have demonstrated that NCAM promotes neuronal functions largely via three main interaction partners: the fibroblast growth factor receptor (FGFR), a member of Src family of tyrosine kinases, Fyn and Raf1 kinase which all activate different intracellular signaling pathways. The objective was to clarify, which signaling pathways are being disrupted in NCAM knockout mice and whether FGL peptide is able to restore observed disruptions. Therefore we compared the levels of phosphorylation of FGFR1, Src kinase Fyn, Raf1 kinase, MAP kinases, Akt kinase and calcium/calmodulin-dependent kinases II and IV (CaMKII and CaMKIV) in the hippocampus of NCAM knockout mice to their wild-type littermates. The data of our study show that mice constitutively deficient in all isoforms of NCAM have decreased basal phosphorylation levels of FGFR1 and CaMKII and CaMKIV. Furthermore, NCAM-mimetic, FGL peptide, is found to be able to restore FGFR1, CaMKII and CaMKIV phosphorylation levels and thereby mimic the interactions of NCAM at this receptor in NCAM deficient mice. Also, we found that Fyn(Tyr530), Raf1, MAP kinases and Akt kinase phosphorylation in adult animals is not affected by NCAM deficiency but interestingly, we found an over-expression of another cell adhesion molecule L1. We conclude that in NCAM deficient mice FGFR1-dependent signaling is disrupted and it can be restored by FGL peptide.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19909731     DOI: 10.1016/j.brainres.2009.11.003

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Immobilized pool of NCAM180 in the postsynaptic membrane is homeostatically replenished by the flux of NCAM180 from extrasynaptic regions.

Authors:  Iryna Leshchyns'ka; Mark M Tanaka; Melitta Schachner; Vladimir Sytnyk
Journal:  J Biol Chem       Date:  2011-05-06       Impact factor: 5.157

Review 2.  The fibroblast growth factor family: neuromodulation of affective behavior.

Authors:  Cortney A Turner; Stanley J Watson; Huda Akil
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

Review 3.  NCAM Mimetic Peptides: Potential Therapeutic Target for Neurological Disorders.

Authors:  Chengyan Chu; Yue Gao; Xiaoyan Lan; Aline Thomas; Shen Li
Journal:  Neurochem Res       Date:  2018-07-12       Impact factor: 3.996

4.  Immune mechanisms linked to depression via oxidative stress and neuroprogression.

Authors:  Nataliia Bakunina; Carmine M Pariante; Patricia A Zunszain
Journal:  Immunology       Date:  2015-01-10       Impact factor: 7.397

Review 5.  Neuritogenic and neuroprotective properties of peptide agonists of the fibroblast growth factor receptor.

Authors:  Shizhong Li; Elisabeth Bock; Vladimir Berezin
Journal:  Int J Mol Sci       Date:  2010-05-26       Impact factor: 5.923

6.  The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling.

Authors:  Silvia Zecchini; Lorenzo Bombardelli; Alessandra Decio; Marco Bianchi; Giovanni Mazzarol; Fabio Sanguineti; Giovanni Aletti; Luigi Maddaluno; Vladimir Berezin; Elisabeth Bock; Chiara Casadio; Giuseppe Viale; Nicoletta Colombo; Raffaella Giavazzi; Ugo Cavallaro
Journal:  EMBO Mol Med       Date:  2011-07-08       Impact factor: 12.137

7.  The Association Between Oxidative Stress and Depressive Symptom Scores in Elderly Population: A Repeated Panel Study.

Authors:  Changwoo Han; Youn-Hee Lim; Yun-Chul Hong
Journal:  J Prev Med Public Health       Date:  2016-08-23

Review 8.  Peptides as Therapeutic Agents for Inflammatory-Related Diseases.

Authors:  Sara La Manna; Concetta Di Natale; Daniele Florio; Daniela Marasco
Journal:  Int J Mol Sci       Date:  2018-09-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.